TARO PHARMS FDA Approval ANDA 215940

ANDA 215940

TARO PHARMS

FDA Drug Application

Application #215940

Application Sponsors

ANDA 215940TARO PHARMS

Marketing Status

Over-the-counter001

Application Products

001GEL;TOPICAL0.1%0ADAPALENEADAPALENE

FDA Submissions

UNKNOWN; ORIG1AP2022-01-14STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

TARO PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215940
            [companyName] => TARO PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ADAPALENE","activeIngredients":"ADAPALENE","strength":"0.1%","dosageForm":"GEL;TOPICAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/14\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-01-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.